1. Home
  2. AGCC vs HYFT Comparison

AGCC vs HYFT Comparison

Compare AGCC & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AGCC

Agencia Comercial Spirits Ltd Class A Ordinary Shares

N/A

Current Price

$14.40

Market Cap

209.9M

ML Signal

N/A

HYFT

MindWalk Holdings Corp.

N/A

Current Price

$1.12

Market Cap

69.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AGCC
HYFT
Founded
2020
1983
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
209.9M
69.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AGCC
HYFT
Price
$14.40
$1.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
55.6K
349.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$51.71
P/E Ratio
$168.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.23
$1.08
52 Week High
$15.47
$3.00

Technical Indicators

Market Signals
Indicator
AGCC
HYFT
Relative Strength Index (RSI) 58.58 29.40
Support Level $8.61 N/A
Resistance Level $14.35 $2.17
Average True Range (ATR) 1.80 0.10
MACD 0.29 -0.01
Stochastic Oscillator 58.95 9.26

Price Performance

Historical Comparison
AGCC
HYFT

About AGCC Agencia Comercial Spirits Ltd Class A Ordinary Shares

Agencia Comercial Spirits Ltd specializes in the procurement, distribution, and sale of high-quality whiskies, including both bottled and cask whisky in both Taiwan and international markets. The company's product portfolio includes the distribution of bottled whisky, raw cask whisky, and proprietary brand whisky.

About HYFT MindWalk Holdings Corp.

MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Share on Social Networks: